Pharming Group (PHAR)
7.53
-0.23
(-2.96%)
USD |
NASDAQ |
Nov 22, 16:00
7.48
-0.05
(-0.66%)
After-Hours: 20:00
Pharming Group Total Assets (Quarterly): 425.51M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 425.51M |
| June 30, 2024 | 415.93M |
| March 31, 2024 | 441.67M |
| December 31, 2023 | 462.85M |
| September 30, 2023 | 436.47M |
| June 30, 2023 | 429.80M |
| March 31, 2023 | 423.00M |
| December 31, 2022 | 425.80M |
| September 30, 2022 | 382.32M |
| June 30, 2022 | 393.90M |
| March 31, 2022 | 392.80M |
| December 31, 2021 | 397.32M |
| September 30, 2021 | 400.91M |
| June 30, 2021 | 412.02M |
| March 31, 2021 | 408.57M |
| December 31, 2020 | 418.45M |
| September 30, 2020 | 374.93M |
| June 30, 2020 | 356.65M |
| March 31, 2020 | 335.22M |
| December 31, 2019 | 255.92M |
| September 30, 2019 | 241.59M |
| June 30, 2019 | 233.99M |
| March 31, 2019 | 224.11M |
| December 31, 2018 | 245.35M |
| September 30, 2018 | 223.94M |
| Date | Value |
|---|---|
| June 30, 2018 | 209.70M |
| March 31, 2018 | 210.43M |
| December 31, 2017 | 199.38M |
| September 30, 2017 | 164.33M |
| June 30, 2017 | 145.24M |
| March 31, 2017 | 140.46M |
| December 31, 2016 | 133.34M |
| September 30, 2016 | 54.81M |
| June 30, 2016 | 59.70M |
| March 31, 2016 | 63.21M |
| December 31, 2015 | 63.06M |
| September 30, 2015 | 69.94M |
| June 30, 2015 | 56.26M |
| March 31, 2015 | 58.21M |
| December 31, 2014 | 67.75M |
| September 30, 2014 | 51.72M |
| June 30, 2014 | 55.93M |
| March 31, 2014 | 45.66M |
| December 31, 2013 | 43.37M |
| September 30, 2013 | 32.01M |
| June 30, 2013 | 37.37M |
| March 31, 2013 | 37.63M |
| December 31, 2012 | 22.28M |
| September 30, 2012 | 20.09M |
| March 31, 2012 | 36.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
255.92M
Minimum
Dec 2019
462.85M
Maximum
Dec 2023
399.50M
Average
410.29M
Median
Total Assets (Quarterly) Benchmarks
| uniQure NV | 645.81M |
| ProQR Therapeutics NV | 119.34M |
| Merus NV | 844.68M |
| argenx SE | -- |
| Pharvaris NV | 349.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 199.72M |
| Shareholders Equity (Quarterly) | 225.79M |
| Debt to Equity Ratio | 0.4226 |
| Current Ratio | 3.534 |
| Net Debt Paydown Yield | 1.45% |